Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forcura is a U.S. healthcare technology company focused on post-acute and home-based care workflow, interoperability, and care coordination. Historically, it provided cloud-based software for referral intake, document workflow, e-signature, secure communication, and data exchange across home health, hospice, physician, and other post-acute providers. Its platform has emphasized interoperability with major home-based care EHRs and AI-enhanced referral and operational workflows. In March 2025, Forcura combined with Medalogix in a transaction led by Berkshire Partners, and in October 2025 the combined company rebranded to Mosai. For biotech and pharma analysts, Forcura is best understood not as a therapeutics developer but as a commercial healthcare software asset serving the post-acute care ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forcura.